Equitable Prenatal Care: Preparing for Future Maternal RSV Vaccinations

Faculty

Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
(Moderator)
Attending, Division of Infectious Diseases
Medical Director, International Patient and Destination Services Program
Vice-President, Lurie Medical/Dental Staff
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL
President-Elect, Infectious Diseases Society of America Board of Directors
Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
(Moderator)

Tina Tan, MD, FAAP, FIDSA, FPIDS, is Professor of Pediatrics at the Feinberg School of Medicine, Northwestern University; and a Pediatric Infectious Diseases attending, Medical Director of the International Patient and Destination Services Program (IPS), co-Director of the Pediatric Travel Medicine Clinic; and Director of the International Adoptee Clinic at Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois. She is currently serving as the Vice President of the Lurie Children’s Hospital Medical/Dental Staff. She is board certified in Pediatrics and Pediatric Infectious Diseases.

Dr. Tan recently served as a member of the Board of Directors of the Infectious Diseases Society of America (IDSA – 2017-2020) and in 2022 was elected as the Vice-President and President elect of the Board of Directors of IDSA. She also served as the chairperson of the IDSA Committee on Diversity, Inclusion, Access & Equity (2017-2022). She has served as Chairperson of the American Academy of Pediatrics (AAP) Section on Infectious Diseases (SOID – 2014-2018) and as a member of the AAP Committee on Infectious Diseases (COID – Redbook Committee – 2010-2018). She currently serves as chairperson of the: AAP Global Immunization Advocacy Project Advisory Committee and is a Technical Advisor for the AAP/CDC Global Immunization Advocacy Project. She is a member of the AAP Antimicrobial Resistance and Stewardship Workgroup – Education Subcommittee, AAP Expert Pertussis Cocooning Advisory Committee, and is a liaison to the CDC ACIP Pertussis Working Group and Polio Working Group and to the Illinois Chapter of the AAP OB/GYN Immunizations and Pregnancy Outreach Committee. She is a member of the American Board of Pediatrics (ABP) Global Health Task Force Dissemination and Advocacy Work Group. Dr. Tan is a member of the Board of Scientific Counselors, Office of Infectious Diseases, Centers for Disease Control and Prevention (CDC) where she serves as co-Chair of the AFM Task Force and the Vaccine Confidence Task Force. She served as a member of the Advisory Commission on Childhood Vaccines of the US Department of Health and Human Services (2016-2019) and as a member of the Vaccine and Related Biologic Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) (2019-2022).

Dr. Tan is the Editor-in-Chief of Contemporary Pediatrics and the American Academy of Pediatric’s Redbook Atlas of Pediatric Infectious Diseases and the Redbook: A Quick Diagnostic Deck. She serves on the editorial boards of the Journal of the Pediatric Infectious Diseases Society (Official Journal of the Pediatric Infectious Diseases Society – PIDS), Internal Medicine Reviews, and Vaccines.

Dr. Tan is the Co-Chairperson and US Representative to the International Steering Committee of the Global Pertussis Initiative (GPI); a member and consultant to the Steering Committee of the Latin America Without Pertussis Initiative (PAHEF, SLIPE); a member of the Expert Pertussis Core Team for Latin America & the Caribbean: Pertussis Action Plan 2020; a member of the Board of Directors of the World Association of Infectious Diseases and Immunological Disorders (WAidid); and a member of the US National Pertussis Task Force (AAP and Every Child by Two).

Dr. Tan’s interests include pertussis disease and vaccines, pneumococcal disease and vaccines, CA-MRSA infections, antibiotic resistance, vaccines and vaccine preventable diseases, general infectious diseases, vaccination of cancer patients with routinely recommended adult preventative vaccines, and vaccine education for healthcare providers and patients.

Kevin A. Ault, MD, FACOG, FIDSA
Professor and Chair
Department of Obstetrics and Gynecology
Western Michigan University Homer Stryker M.D. School of Medicine
Kalamazoo, MI
Kevin A. Ault, MD, FACOG, FIDSA

Kevin A. Ault, MD, FACOG, FIDSA, is Professor and Chair of the Department of Obstetrics and Gynecology at the Western Michigan University Homer Stryker M.D. School of Medicine. Dr. Ault is a former member of the CDC’s Advisory Committee on Immunization Practice and is an author on current guidelines concerning maternal immunization, including RSV.

LaToshia Rouse, CD/PCD(DONA)
Certified Doula and Patient Engagement Consultant
Owner of Birth Sisters Doula Services
Raleigh, NC
LaToshia Rouse, CD/PCD(DONA)

LaToshia Rouse is a certified birth and postpartum doula/owner of Birth Sisters Doula Services, as well as a Patient and Family Engagement Consultant. She contracts with Institute of Patient and Family Centered Care (IPFCC), the University of Chapel Hill and several organizations to offer her expertise in patient engagement, doulas, and equity. Her journey began as a patient partner 10 years ago, after having triplets at 26 weeks gestation via an emergency vaginal delivery. Early on, LaToshia’s work focused on bringing the parent perspective to the newborn intensive care unit (NICU) and antepartum improvement committees at WakeMed Health and Hospitals, including serving as a member of the NICU’s Vermont Oxford Network (VON) team. LaToshia has served as a subject matter expert and expert team member for the National Network of Perinatal Quality Collaboratives (NNPQC), American Board of Pediatrics (ABP), American College of Obstetricians and Gynecologists (ACOG), and many other organizations.

Ms. Rouse’s work has spanned all levels of healthcare, with work in research, policy, executive committee level, and board of directors with the American Board of Pediatrics (ABP) and the National Institute for Children’s Health Quality (NICHQ). She worked on policy with the North Carolina Institute of Medicine’s (NCIOM) Maternal Health Taskforce and worked on policy as Co-Chair of the NCIOM’s Taskforce on the Perinatal System of Care in 2019. Her measurement work started in 2020, with the Maternal and Child Health- Measurement Research Network where she Co-Chairs the Equity Committee for the project. She is also a Co-Chair of the (National Network of Perinatal Quality Collaboratives) NNPQC’s Executive Committee. LaToshia completed her Diversity and Inclusion Certification at Cornell University to further impact equity for families, moms, and babies. The opportunity to sit on National Committee for Quality Assurance (NCQA)’s HEDIS and Health Equity Expert Work Group has been one of those opportunities. In reflecting on the work she’s engaged in over the last number of years, LaToshia’s passion is finding ways for clinicians and patients to have a true partnership and improve outcomes.

Statement of Need

Routine prenatal vaccine administration, such as that of influenza or tetanus, diphtheria, and acellular pertussis (Tdap), is a cornerstone of prenatal care and an important part of public health efforts to prevent disease. Respiratory syncytial virus (RSV) is a highly contagious virus that can result in severe respiratory complications, and infants, especially those younger than age 1, are particularly vulnerable to the dangers of RSV. While all infants can be exposed to and affected by RSV, underserved communities that experience systemic disadvantages face greater barriers to health care access. Uptake of prenatal vaccination in the United States remains low and a powerful educational initiative that provides expert analysis of the available data for maternal RSV vaccination is needed.

In this CMEO Webcast, expert faculty will discuss strategies to evaluate the latest data for RSV maternal vaccination, assess the impact of RSV disease on infants, pregnant individuals, and the health care system at large, particularly among underserved populations, and integrate actionable strategies to address real-world implementation-related challenges of maternal RSV vaccination, with a focus on guidelines and tools to overcome barriers to access.

Learning Objectives

  • Evaluate the latest data for RSV maternal vaccination including protection for infants from severe RSV infections
  • Assess the impact of RSV disease on infants, pregnant individuals, and the health care system at large, particularly among underserved populations
  • Integrate actionable strategies to address real-world implementation-related challenges of maternal RSV vaccination, with a focus on guidelines and tools to overcome barriers to access

Financial Support

This activity is supported by an educational grant from Pfizer, Inc.

Target Audience

OB/GYNs, family medicine physicians, maternal-fetal medicine specialists, nurse midwives, doulas, community health workers, nurse practitioners (NPs), nurse navigators, and physician associates (PAs)

Credit Information

Jointly accredited provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours ( 0.1 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-126-H01-P ).

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 12/07/2024. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Tan reports the following financial relationships:

Grants: AstraZeneca and GSK

Consultant: GSL; ILiAD Biotechnologies; Merck & Co., Inc.; Moderna, Inc.; Novavax; Pfizer Inc.; and Sanofi Pasteur

Dr. Ault reports no financial relationships to disclose.

Ms. Rouse reports no financial relationships to disclose.

Disclosures were obtained from the following peer reviewer and CME Outfitters, LLC, staff, with no disclosures to report:

  • Rebecca Vargas-Jackson, MD (peer reviewer)
  • Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)
  • Evan Luberger (planning committee)
  • Erin Spencer (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WCV-078-120623-02

Equitable Prenatal Care: Preparing for Future Maternal RSV Vaccinations
Event Date: 12/13/2023 at 5:00 am EST